期刊文献+

莫西沙星治疗急性下呼吸道感染30例临床分析 被引量:1

暂未订购
导出
摘要 目的:探讨临床应用莫西沙星治疗急性下呼吸道感染的治疗效果。方法:随机选取进行诊治的急性下呼吸道感染患者30例,并将其分为莫西沙星组和左氧氟沙星组进行治疗,同时对患者的临床指标变化、细菌学及安全性进行观察对比,分析其治疗效果。结果:经对比得知,莫西沙星组的细胞清除率为93%,左氧氟沙星总有效率为73%,差异有统计学意义(P<0.05),两组细菌清除率差异无统计学意义(P>0.05)。莫西沙星组患者痊愈10例,显效4例,总有效率为93%;左氧氟沙星组痊愈9例,显效2例,总有效率为73%,结果比较,差异有统计学意义(P<0.05)。治疗前后未见严重不良反应发生。结论:临床应用莫西沙星对急性下呼吸道感染进行治疗,具有起效快、安全性较高等特点,值得临床应用及推广。
作者 隋韶光
出处 《吉林医学》 CAS 2011年第12期2367-2368,共2页 Jilin Medical Journal
  • 相关文献

参考文献4

二级参考文献22

  • 1Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
  • 2Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
  • 3Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
  • 4Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
  • 5Heffelfinger JD,Dowell SF,Jorgensen JH,et al.Management of community-acquired pneumonia in the era of pneumococcal resistance:a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group.Arch Intern Med,2000,160:1399-1408.
  • 6Niederman MS,McCombs JS,Unger AN,et al.The cost of treating community-acquired pneumonia.Clin Ther,1998,20:820-837
  • 7Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia:diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754
  • 8Dunbar LM,Wunderink RG,Habib MP,et al.High-dose,short-course levofloxacin for community-acquired pneumonia:a new treatment paradigm.Clin Infect Dis,2003,7:752-760
  • 9Finch R,Schurmann D,Collins O,et al.Randomized controlled trial of sequential intravenous (i.v.) and oral moxifloxacin compared with sequential i.v. and oral co-amoxiclav with or without clarithromycin in patients with community-acquired pneumonia requiring initial parenteral treatment.Antimicrob Agents Chemother,2002,46,1746-1754
  • 10Faich GA,Morganroth J,Whitehouse AB,et al.Clinical experience with moxifloxacin in patients with respiratory tract infections.Ann Pharmacother,2004,38:749-754

共引文献1033

同被引文献8

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部